-
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
28 Mar 2024 15:21 GMT
… Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024 … Affairs Oncology Business Group at Eisai. We are particularly pleased to …
-
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript
27 Mar 2024 13:56 GMT
… , Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript March 26, 2024 … thinking, especially with regards to Eisai’s recent pushbacks for subcutaneous …
-
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2023 Earnings Call Transcript
22 Mar 2024 14:43 GMT
… . (NASDAQ:HYPR) Q4 2023 Earnings Call Transcript March 21, 2024 …
Hyperfine, Inc. beats earnings expectations. Reported EPS is $-0 … and Fiscal Year 2023 Earnings Conference Call. At this … CMS reimbursement of Biogen Eisai LEQEMBI and Amyloid Targeting …
-
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript
28 Feb 2024 14:42 GMT
… NASDAQ:LGND) Q4 2023 Earnings Call Transcript February 27, … 2024
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is … Last month, we saw Eisai announce the approval of … to our fourth quarter earnings press release issued earlier …
-
Biogen Inc. (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript
14 Feb 2024 14:26 GMT
… . (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript February 13, 2024 … working alongside our colleagues from Eisai on the launch in … with the IV formulation. Eisai has communicated very recently about … evolved with your partnership with Eisai where you think you …
-
Biogen (BIIB) Q4 2023 Earnings Call Transcript
13 Feb 2024 19:47 GMT
… ll remind you that the earnings release and related financial … pleasure that we can announce earnings guidance, which Mike will … currency. Non-GAAP diluted earnings per share in the fourth … clear, Eisai has communicated as recently as their earnings a few …
-
Biogen (BIIB): Earnings Alert - Key Insights
13 Feb 2024 01:16 GMT
… its fiscal 2023 fourth-quarter earnings on February 13. Analysts predict … launch of LEQEMBI, together with Eisai, and continue to bolster innovation …
-
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
08 Feb 2024 15:19 GMT
… Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 …
Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0 … we saw the release from Eisai and the pickup of the …
-
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi
07 Feb 2024 16:41 GMT
… coverage that distinction brings, Eisai and Biogen’s latest Alzheimer … Jan. 26, Eisai explained in a third-quarter earnings presentation.
That … on treatment, Keisuke Naito, Eisai’s global Alzheimer’s … the coming few months, Eisai expects the number of patients …
-
Eisai to Likely Miss Patient Goal for Leqembi by End of March 2024
07 Feb 2024 15:16 GMT
… -quarter fiscal year 2023 earnings report, Eisai revealed that the launch … investor call, Keisuke Naito, Eisai’s global Alzheimer’s disease … triaging and confirmatory testing, Eisai will also be able to … to patients.”
Developed by Eisai and Biogen, Leqembi is …